Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P400PM_183865)
Gottfried und Julia Bangerter-Rhyner-Stiftung
Received: 24 February 2020
Accepted: 26 June 2020
First Online: 8 July 2020
Ethics approval and consent to participate
: All studies were approved by the national ethics committee.
: Not applicable.
: The authors declare that they have no competing interests. JFT received fees for lectures to 3 M, MSD, Pfizer, and Biomerieux. JFT received research grants from Astellas, 3 M, MSD, and Pfizer. JFT participated to advisory boards of 3 M, MSD, Bayer Pharma, Nabriva, and Pfizer. JCL received fees for lectures for 3 M, Pfizer MSD, and research grants from Anios. OM received fees for lectures for 3 M and BD. OM received research grants from BD.